WallStreetZenWallStreetZen

NASDAQ: NCNA
Nucana PLC Stock Forecast, Predictions & Price Target

Analyst price target for NCNA

Based on 1 analyst offering 12 month price targets for Nucana PLC.
Min Forecast
$4.00+1,438.46%
Avg Forecast
$4.00+1,438.46%
Max Forecast
$4.00+1,438.46%

Should I buy or sell NCNA stock?

Based on 1 analyst offering ratings for Nucana PLC.
Buy
Strong Buy
0 analysts 0%
Buy
1 analysts 100%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%

Be the first to know when Wall Street analysts revise their NCNA stock forecasts and price targets.

NCNA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2023-11-21

1 of 1

Forecast return on equity

Is NCNA forecast to generate an efficient return?
Company
N/A
Industry
N/A
Market
37.27%

Forecast return on assets

Is NCNA forecast to generate an efficient return on assets?
Company
N/A
Industry
N/A

NCNA revenue forecast

What is NCNA's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$3.0M
Avg 2 year Forecast
$9.0M
Avg 3 year Forecast
$69.8M

NCNA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NCNA$0.26$4.00+1,438.46%Buy
NNVC$1.16$6.50+460.34%Strong Buy
ABVC$1.31N/AN/A
BNTC$5.25$10.00+90.48%Buy
IKT$2.16$27.00+1,150.00%Buy

Nucana Stock Forecast FAQ

Is Nucana Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: NCNA) stock is to Buy NCNA stock.

Out of 1 analyst, 0 (0%) are recommending NCNA as a Strong Buy, 1 (100%) are recommending NCNA as a Buy, 0 (0%) are recommending NCNA as a Hold, 0 (0%) are recommending NCNA as a Sell, and 0 (0%) are recommending NCNA as a Strong Sell.

If you're new to stock investing, here's how to buy Nucana stock.

What is NCNA's revenue growth forecast for 2025-2027?

(NASDAQ: NCNA) Nucana's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 39.22%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.52%.

Nucana's revenue in 2024 is $0.On average, 1 Wall Street analysts forecast NCNA's revenue for 2025 to be $158,581,005, with the lowest NCNA revenue forecast at $158,581,005, and the highest NCNA revenue forecast at $158,581,005. On average, 1 Wall Street analysts forecast NCNA's revenue for 2026 to be $475,743,015, with the lowest NCNA revenue forecast at $475,743,015, and the highest NCNA revenue forecast at $475,743,015.

In 2027, NCNA is forecast to generate $3,687,008,366 in revenue, with the lowest revenue forecast at $951,486,030 and the highest revenue forecast at $6,422,530,703.

What is NCNA's forecast return on assets (ROA) for 2024-2027?

(NASDAQ: NCNA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of N/A.

What is NCNA's Price Target?

According to 1 Wall Street analyst that have issued a 1 year NCNA price target, the average NCNA price target is $4.00, with the highest NCNA stock price forecast at $4.00 and the lowest NCNA stock price forecast at $4.00.

The Wall Street analyst predicted that Nucana's share price could reach $4.00 by Nov 21, 2024. The average Nucana stock price prediction forecasts a potential upside of 1,438.46% from the current NCNA share price of $0.26.

What is NCNA's forecast return on equity (ROE) for 2024-2027?

(NASDAQ: NCNA) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.